Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. There are limited data on the safety of fondaparinux for [[Venous thromboembolic prophylaxis]] VTE prophylaxis in ischemic stroke. Fondaparinux is not associated with increased hemorrhagic complications compared with Unfractionated heparin (UFH) in patients with [[ischemic stroke]]. There were low rates of symptomatic VTE in both groups ((Hackett CT, Ramanathan RS, Malhotra K, Quigley MR, Kelly KM, Tian M, Protetch J, Wong C, Wright DG, Tayal AH. Safety of venous thromboembolism prophylaxis with fondaparinux in ischemic stroke. Thromb Res. 2015 Feb;135(2):249-54. doi: 10.1016/j.thromres.2014.11.041. Epub 2014 Dec 13. PubMed PMID: 25554497. )). fondaparinux.txt Last modified: 2024/06/07 02:56by 127.0.0.1